BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 31366597)

  • 1. CONSORT 2010 statement: extension to randomised crossover trials.
    Dwan K; Li T; Altman DG; Elbourne D
    BMJ; 2019 Jul; 366():l4378. PubMed ID: 31366597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the quality of reports of randomised controlled trials: the CONSORT statement.
    Otwombe KN; Ogutu B
    East Afr Med J; 2002 Jul; 79(7):394-6. PubMed ID: 12638837
    [No Abstract]   [Full Text] [Related]  

  • 3. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    J Clin Epidemiol; 2010 Aug; 63(8):834-40. PubMed ID: 20346629
    [No Abstract]   [Full Text] [Related]  

  • 4. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    BMC Med; 2010 Mar; 8():18. PubMed ID: 20334633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    Trials; 2010 Mar; 11():32. PubMed ID: 20334632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.
    Schulz KF; Altman DG; Moher D;
    BMJ; 2010 Mar; 340():c332. PubMed ID: 20332509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
    Schulz KF; Altman DG; Moher D;
    Ann Intern Med; 2010 Jun; 152(11):726-32. PubMed ID: 20335313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
    Piaggio G; Elbourne DR; Altman DG; Pocock SJ; Evans SJ;
    JAMA; 2006 Mar; 295(10):1152-60. PubMed ID: 16522836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CONSORT 2010 statement: updated guidelines can improve wound care.
    Weller C; McNeil J
    J Wound Care; 2010 Aug; 19(8):347-53. PubMed ID: 20852507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CONSORT statement. Revised findings on quality improvement based on reports from randomized studies in parallel design].
    Moher D; Schulz KF; Altman DG;
    Schmerz; 2005 Apr; 19(2):156-62. PubMed ID: 15700113
    [No Abstract]   [Full Text] [Related]  

  • 12. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
    Bian ZX; Shang HC
    Ann Intern Med; 2011 Feb; 154(4):290-1; author reply 291-2. PubMed ID: 21320945
    [No Abstract]   [Full Text] [Related]  

  • 13. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
    Schulz KF; Altman DG; Moher D;
    Obstet Gynecol; 2010 May; 115(5):1063-1070. PubMed ID: 20410783
    [No Abstract]   [Full Text] [Related]  

  • 14. CONSORT statement: extension to cluster randomised trials.
    Campbell MK; Elbourne DR; Altman DG;
    BMJ; 2004 Mar; 328(7441):702-8. PubMed ID: 15031246
    [No Abstract]   [Full Text] [Related]  

  • 15. [The CONSORT statement for cluster randomised trials].
    Campbell MK; Elbourne DR; Altman DG;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():28-31. PubMed ID: 16464424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting quality of life in clinical trials: a CONSORT extension.
    Calvert M; Blazeby J; Revicki D; Moher D; Brundage M
    Lancet; 2011 Nov; 378(9804):1684-5. PubMed ID: 22078674
    [No Abstract]   [Full Text] [Related]  

  • 17. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):W60-6. PubMed ID: 18283201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the quality of reporting in randomised controlled trials.
    Walker A; Nixon J
    J Wound Care; 2004 Mar; 13(3):103-6. PubMed ID: 15045804
    [No Abstract]   [Full Text] [Related]  

  • 19. [The CONSORT statenent: Revised Recommendations For Improving the Quality of Reports of Parallel-Group Randomized Trials].
    Moher D; Schulz KF; Altman DG;
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Jul; 25(7):658-61. PubMed ID: 16089150
    [No Abstract]   [Full Text] [Related]  

  • 20. Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond.
    Moher D; Altman DG; Schulz KF; Elbourne DR
    CMAJ; 2004 Aug; 171(4):349-50. PubMed ID: 15313995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.